EHang Announces Appointment of Co-Chief Operating Officer
GUANGZHOU, China, April 09, 2024 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading […]
GUANGZHOU, China, April 09, 2024 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading […]
NUREMBERG, Germany, April 09, 2024 (GLOBE NEWSWIRE) — Embedded World — Micron Technology, Inc. (Nasdaq: MU), today announced it is sampling […]
HAUPPAUGE, N.Y., April 08, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (the “Company” or “Dime”) (NASDAQ: DCOM), the parent […]
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing […]
MELBOURNE, Australia and PRINCETON, N.J., April 08, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage […]
SYDNEY, Australia, April 08, 2024 (GLOBE NEWSWIRE) — Vast Renewables Limited (Vast) (Nasdaq: VSTE) and 1414 Degrees Limited (ASX:14D), through their […]
LOUISVILLE, Ky., April 08, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN, “CDI,” or the “Company”) announced today that […]
WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), today announced that […]
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — Verita (Verita CSG, Inc.), a Managing General Underwriting (MGU) company, is excited […]
SAN FRANCISCO, April 08, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company […]